The pharmaceutical sector is experiencing a important shift in diabetes therapy with the arrival of GLP-1 patches. These innovative vehicles offer a possibly simple option to subcutaneous injections for individuals managing diabetes. By circumventing the requirement for frequent pokes, GLP-1 skin devices promise to improve patient adherence and … Read More